Document Detail

Cerebral β-amyloid detected by Pittsburgh compound B positron emission topography predisposes to recombinant tissue plasminogen activator-related hemorrhage.
MedLine Citation:
PMID:  20661925     Owner:  NLM     Status:  MEDLINE    
Cerebral amyloid angiopathy (CAA) may be an important predisposing factor for the hemorrhagic complications of recombinant tissue-type plasminogen activator (rt-PA) therapy. We studied patients treated within 3 hours of onset of ischemic stroke with rt-PA using positron emission tomography to compare Pittsburgh compound B (PiB) (a cerebral β-amyloid ligand) retention in those with and without parenchymal hemorrhage (PH) and normal controls. Neocortical PiB retention was higher among patients with PH compared with patients without PH and normal controls, suggesting underlying CAA as a predisposing factor for rt-PA-related hemorrhage. This finding may provide an impetus for the development of a more practical rapid pretreatment screening technique.
John V Ly; Christopher C Rowe; Victor L Villemagne; Jorge A Zavala; Henry Ma; Graeme O'Keefe; Sylvia J Gong; Rico Gunawan; Leonid Churilov; Tim Saunder; Uwe Ackerman; Henri Tochon-Danguy; Geoffrey A Donnan
Related Documents :
25347055 - Carotid hemodynamics is associated with monocyte count determined by serum homocysteine...
18978245 - Mimicking of cerebral herniation through gamma-hydroxybutyric acid therapy.
1383855 - Evaluation of therapeutically induced hypertension in patients with delayed cerebral va...
25458655 - Is mechanical dyssynchrony a therapeutic target in heart failure with preserved ejectio...
19756765 - Comparison between fractional excretions of urea and sodium in children with acute kidn...
23623345 - 1:1 atrial-flutter. prevalence and clinical characteristics.
Publication Detail:
Type:  Journal Article    
Journal Detail:
Title:  Annals of neurology     Volume:  68     ISSN:  1531-8249     ISO Abbreviation:  Ann. Neurol.     Publication Date:  2010 Dec 
Date Detail:
Created Date:  2011-01-03     Completed Date:  2011-01-31     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  7707449     Medline TA:  Ann Neurol     Country:  United States    
Other Details:
Languages:  eng     Pagination:  959-62     Citation Subset:  IM    
National Stroke Research Institute, Austin Health, University of Melbourne, Heidelberg Heights, Australia.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Benzothiazoles / diagnostic use*
Cerebral Amyloid Angiopathy / etiology,  radionuclide imaging*
Fibrinolytic Agents / adverse effects*
Hemorrhage / chemically induced*,  complications*
Magnetic Resonance Imaging / methods
Positron-Emission Tomography / methods
ROC Curve
Retrospective Studies
Stroke / drug therapy
Tissue Plasminogen Activator / adverse effects*
Reg. No./Substance:
0/Benzothiazoles; 0/Fibrinolytic Agents; 0/N-methyl-2-(4'-methylaminophenyl)-6-hydroxybenzothiazole; EC Plasminogen Activator

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Reciprocal Th1 and Th17 regulation by mesenchymal stem cells: Implication for multiple sclerosis.
Next Document:  Does exercise correct dysregulation of neurosteroid levels induced by epilepsy?